# Clinical Proof-of-concept Study on Immune Surveillance and Alertness

> **NCT05431751** · NA · UNKNOWN · sponsor: **Natural Immune Systems Inc** · enrollment: 24 (estimated)

## Conditions studied

- Immune Surveillance

## Interventions

- **DIETARY_SUPPLEMENT:** Whole Algae

## Key facts

- **NCT ID:** NCT05431751
- **Lead sponsor:** Natural Immune Systems Inc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-12
- **Primary completion:** 2022-10-31
- **Final completion:** 2023-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05431751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05431751, "Clinical Proof-of-concept Study on Immune Surveillance and Alertness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05431751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*